Literature DB >> 10982709

Measurement of atrial septal defect size: a comparative study between three-dimensional transesophageal echocardiography and the standard balloon sizing methods.

W Zhu1, Q L Cao, J Rhodes, Z M Hijazi.   

Abstract

Atrial septal defect (ASD) size measurement is of paramount importance for the successful deployment of a transcatheter septal occluder. The stretched balloon diameter (SBD) has long been regarded as the gold standard for selection of the size of any device. Three-dimensional (3-D) transesophageal echocardiography (TEE) can visualize the overall structure of the atrial septum, therefore rendering an accurate size of the ASD. In this study we aimed to validate the accuracy of ASD size measurement by 3-D TEE and to elucidate the reason for the difference between balloon sizing and 3-D measurement. Forty-one consecutive patients were enrolled in this protocol for ASD device closure using the Amplatzer septal occluder. Thirty-nine patients were diagnosed by 2-D transthoracic echocardiography as secundum ASD and 2 patients were diagnosed as patent foramen ovale. Two measurements of the balloon size were sequentially obtained by 2-D TEE after the balloon was fully inflated in the left atrium. First, no residual shunt across the septum could be seen while the balloon was pulled back against the septum. This measurement was called the balloon occlusive diameter (BOD). Second, with balloon deflation, a slight deformity of the balloon was seen just prior to its popping through the septum. This measurement was called the stretched balloon diameter (SBD). Three-dimensional TEE was performed in all patients at the beginning of the procedure before device deployment and within 15 minutes after device release. Three-dimensional TEE provided superior views of the ASDs, showing the spatial relationship between the ASD and the neighboring structures. For maximal ASD size measurement, balloon sizing was larger than 3-D TEE examination, whereas 2-D was smaller than the other two methods. The best correlation was found between 3-D TEE measurements and the BOD (r = 0.98, p < 0.0001). Three-dimensional TEE provides en face view of ASD; thus, it can accurately measure the size of ASD. Three-dimensional TEE measurement of ASD can be used instead of balloon sizing for the selection of transcatheter ASD occluder size.

Entities:  

Mesh:

Year:  2000        PMID: 10982709     DOI: 10.1007/s002460010111

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  15 in total

1.  Atrial septal defects type II: noninvasive evaluation of patients before implantation of an Amplatzer Septal Occluder and on follow-up by magnetic resonance imaging compared with TEE and invasive measurement.

Authors:  Christoph Weber; Michael Weber; Okan Ekinci; Thomas Neumann; Anja Deetjen; Andreas Rolf; Gerhard Adam; Christian W Hamm; Thorsten Dill
Journal:  Eur Radiol       Date:  2008-06-21       Impact factor: 5.315

2.  Assessment of atrial septal defect size and residual rim using real-time 3D transesophageal echocardiography.

Authors:  Kyoko Kaku; Masaaki Takeuchi; Lissa Sugeng; Joseph A Lodato; Hiromi Nakai; Lynn Weinert; Kyoko Otani; Hidetoshi Yoshitani; Nobuhiko Haruki; Ziyad M Hijazi; Yutaka Otsuji; Roberto M Lang
Journal:  J Echocardiogr       Date:  2009-07-14

3.  How to Size ASDs for Percutaneous Closure.

Authors:  Isabelle Boon; Katrien Vertongen; Bernard P Paelinck; Laurent Demulier; An Van Berendoncks; Catherine De Maeyer; Fabienne Marchau; Joseph Panzer; Kristof Vandekerckhove; Daniel De Wolf
Journal:  Pediatr Cardiol       Date:  2017-09-27       Impact factor: 1.655

4.  Assessment of atrial septal defects in adults comparing cardiovascular magnetic resonance with transoesophageal echocardiography.

Authors:  Karen S L Teo; Patrick J Disney; Benjamin K Dundon; Matthew I Worthley; Michael A Brown; Prashanthan Sanders; Stephen G Worthley
Journal:  J Cardiovasc Magn Reson       Date:  2010-07-22       Impact factor: 5.364

5.  Predictors of successful transcatheter closure of atrial septal defect by cardiac magnetic resonance imaging.

Authors:  K Durongpisitkul; N L Tang; J Soongswang; D Laohaprasitiporn; A Nanal
Journal:  Pediatr Cardiol       Date:  2003-12-15       Impact factor: 1.655

6.  Morphologic Characteristics and Relating Factors to the Need of Technical Modification in Transcatheter Closure of Large Atrial Septal Defect (>/=25 mm).

Authors:  Su-Jin Park; Nam Kyun Kim; Jung Ok Kim; Byung Won Yoo; Jae Young Choi; Jun Hee Sul
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

Review 7.  Echocardiography guidance of atrial septal defect closure.

Authors:  Bushra S Rana
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

8.  Transcatheter Device Closure of Secundum Atrial Septal Defect in Adult Patient.

Authors:  Nabil Naser; Nura Hadziomerovic; Sevleta Avdic
Journal:  Acta Inform Med       Date:  2021-03

9.  Patent ductus arteriosus device embolization.

Authors:  K Iqbal; Sm Ali; Na Tramboo; Aa Lone; S Kaul; N Kaul; I Hafiz
Journal:  Images Paediatr Cardiol       Date:  2011-01

10.  Measurement of Atrial Septal Defect Size: A Comparative Study between Transesophageal Echocardiography and Balloon Occlusive Diameter Method.

Authors:  Hakimeh Sadeghian; Alimohammad Hajizeinali; Bahareh Eslami; Masoumeh Lotfi-Tokaldany; Mahmood Sheikhfathollahi; Mohammad Sahebjam; Elham Hakki; Arezou Zoroufian; Seyed Ebrahim Kassaian; Mohammad Alidoosti
Journal:  J Tehran Heart Cent       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.